Table 4.
Barriers to opioid analgesic prescription (N = 636).
| Strongly agree | Somewhat agree | Somewhat disagree | Strongly disagree | Does not apply | |
|---|---|---|---|---|---|
| %∗ | %∗ | %∗ | %∗ | %∗ | |
| Difficulty in properly evaluating/establishing a clear diagnosis of CNCP | 13.1 | 41.7 | 32.7 | 10.8 | 1.7 |
| Extra work linked to opioid treatment | 6.34 | 23.2 | 42.9 | 24.9 | 2.3 |
| CNCP patients tend to be “heavy cases” | 13.2 | 34.2 | 31.9 | 18.2 | 2.6 |
| Adverse effects | 19.62 | 50.1 | 24.6 | 4.8 | 1.0 |
| Risk of abuse, misuse, or diversion | 26.9 | 45.6 | 22.9 | 3.6 | 1.1 |
| Risk of dependence | 29.3 | 43.9 | 20.4 | 5.3 | 1.2 |
| Risk of overdose | 11.7 | 35.0 | 41.5 | 10.3 | 1.6 |
| Risk of tolerance | 16.8 | 41.7 | 31.2 | 9.5 | 0.8 |
| Lack of professional support in treating the pain | 30.0 | 36.2 | 24.1 | 7.9 | 1.8 |
| Lack of professional support in the event of abuse or dependence | 36.1 | 39.3 | 17.2 | 4.8 | 2.7 |
| Risk of inspection or professional sanctions | 3.3 | 15.1 | 40.2 | 39.2 | 2.3 |
| Lack of proof that opioid analgesics are effective for CNCP in the long term | 8.6 | 28.4 | 41.7 | 18.2 | 3.10 |
∗Weighted proportions.